期刊文献+
共找到9篇文章
< 1 >
每页显示 20 50 100
非小细胞肺癌新辅助免疫治疗的预后影响因素:病理淋巴结转移程度与原发灶缓解程度
1
作者 徐源 梁乃新 刘洪生 《首都医科大学学报》 CAS 北大核心 2024年第4期649-653,共5页
目的探讨新辅助免疫治疗后病理淋巴结转移情况及原发灶缓解程度对非小细胞肺癌(non-small cell lung cancer,NSCLC)患者预后的影响。方法回顾性分析40例接受新辅助免疫治疗后行手术切除的NSCLC患者的临床病理资料。评估病理淋巴结分期(N... 目的探讨新辅助免疫治疗后病理淋巴结转移情况及原发灶缓解程度对非小细胞肺癌(non-small cell lung cancer,NSCLC)患者预后的影响。方法回顾性分析40例接受新辅助免疫治疗后行手术切除的NSCLC患者的临床病理资料。评估病理淋巴结分期(N1/N2)和原发灶缓解程度[完全缓解(pathological complete response,pCR)/主要缓解(major pathological response,MPR)/非客观缓解(non-objective response,non-OR)]与无进展生存期(progression-free survival,PFS)的关系,并构建预后风险分层模型。结果病理淋巴结分期和原发灶缓解程度单独考虑时,与PFS无显著相关性,且两者无显著交互作用。对于N1患者,pCR/MPR的PFS优于non-OR(P=0.038);对于N2患者,原发灶缓解程度与PFS无显著相关性。将患者分为低危组(N1+pCR/MPR)和高危组(N1+non-OR/N2),两组PFS差异显著(P=0.003)。结论新辅助免疫治疗后,病理淋巴结转移程度和原发灶缓解程度是NSCLC预后的关键影响因素。基于两者的预后风险分层模型有助于指导个体化治疗决策,但仍需前瞻性研究验证。 展开更多
关键词 非小细胞肺癌 新辅助免疫治疗 病理淋巴结转移 原发灶缓解 预后
下载PDF
甲状腺乳头状癌超声征象特征和颈部淋巴结转移的相关性 被引量:3
2
作者 黄珊 张准 高珊 《中国卫生标准管理》 2023年第13期128-132,共5页
目的分析甲状腺乳头状癌的超声征象特征及其与颈部淋巴结转移的相关性。方法选取中南大学湘雅三医院外科2023年2—4月手术后慢速病理确诊为甲状腺乳头状癌的患者102例。根据术前甲状腺及颈部淋巴结彩超评估结果,将患者分为临床转移组(n=... 目的分析甲状腺乳头状癌的超声征象特征及其与颈部淋巴结转移的相关性。方法选取中南大学湘雅三医院外科2023年2—4月手术后慢速病理确诊为甲状腺乳头状癌的患者102例。根据术前甲状腺及颈部淋巴结彩超评估结果,将患者分为临床转移组(n=13)与临床非转移组(n=89);根据术后病理结果,将患者分为病理转移组(n=43)与病理非转移组(n=59)。对所有研究对象的超声检查及病理结果结果开展回顾性分析,比较超声征象特征,分析其与颈部淋巴结病理转移的相关性。结果术前彩超评估颈部淋巴结转移率为12.75%,术后病理颈部淋巴结转移率为42.16%。病理转移组的结节直径(≥1.5 cm)、钙化(是否发生)的超声征象特征与病理非转移组比较,差异有统计学意义(P<0.05);两组的边界(是否清晰)、形态(是否规则)、纵横比(≥1)、回声质地(是否均匀)、内部血供丰富、距被膜距离比较,差异无统计学意义(P>0.05)。通过Logistic回归分析发现,结节直径、钙化为甲状腺颈部淋巴结病理转移发生的独立危险因素(P<0.05)。结论对于甲状腺乳头状癌患者,可在一定程度上根据其超声征象特征来评估颈部淋巴结发生病理转移风险的高低。此文的研究结果为甲状腺乳头状癌超声征象特征后期标准制定提供了借鉴内容。 展开更多
关键词 甲状腺乳头状癌 超声征象特征 颈部淋巴结病理转移 相关性 钙化 彩超
下载PDF
T_2期直肠癌淋巴结转移的相关临床病理因素分析 被引量:4
3
作者 陈悦 王永鹏 +3 位作者 宋纯 刘放 马思平 张睿 《中国现代普通外科进展》 CAS 2013年第5期400-402,共3页
探讨T2期直肠癌淋巴结转移及跳跃性转移的特点。本研究回顾性分析231例T2期直肠癌患者淋巴结转移及51例发生淋巴结转移患者中跳跃性淋巴结转移与临床病理资料之间的关系,用χ2检验和Fisher’s精确概率法分析其相关因素。研究发现高中分... 探讨T2期直肠癌淋巴结转移及跳跃性转移的特点。本研究回顾性分析231例T2期直肠癌患者淋巴结转移及51例发生淋巴结转移患者中跳跃性淋巴结转移与临床病理资料之间的关系,用χ2检验和Fisher’s精确概率法分析其相关因素。研究发现高中分化T2期直肠癌发生淋巴结转移及跳跃性淋巴结转移率相对较低,进行局部切除的可行性较大。 展开更多
关键词 直肠癌·淋巴结·转移·临床病理因素
下载PDF
临床与病理评估无淋巴结转移的肝内胆管癌患者术后预后对比 被引量:2
4
作者 林谦益 简志威 +2 位作者 彭竞源 林义乐 劳向明 《中国肿瘤临床》 CAS CSCD 北大核心 2021年第14期703-710,共8页
目的:比较肝内胆管癌(intrahepatic cholangiocarcinoma,ICC)中临床评估无淋巴结转移且未行淋巴结切除(clinically node-negative without lymphadenectomy,cN0/LND-)和病理评估无淋巴结转移(pathologically node-negative,pN0)患者的... 目的:比较肝内胆管癌(intrahepatic cholangiocarcinoma,ICC)中临床评估无淋巴结转移且未行淋巴结切除(clinically node-negative without lymphadenectomy,cN0/LND-)和病理评估无淋巴结转移(pathologically node-negative,pN0)患者的术后生存差异。从预后的角度探讨在ICC中cN0能否作为pN0的替代指标。方法:检索SEER数据库2004~2017年行部分肝切除术且无远处转移的ICC患者。经倾向性评分匹配(propensity-score matching,PSM)后分为下述3个部分进行生存比较:cN0/LND-vs.pN0[淋巴结切除数(harvested lymph nodes,HLN)>0枚];cN0/LND-vs.pN0(HLN≥6枚);pN0(HLN≥6枚)vs.pN0(HLN<6枚)。结果:PSM后,pN0组(HLN>0枚)总生存时间(overall survival,OS)显著长于cN0/LND-组[中位OS(median OS,mOS):54个月vs.44个月,P=0.038],多因素分析结果提示pN0(HLN>0枚)为预后良好的独立相关因素(P<0.05)。并且HLN≥6枚淋巴结的pN0患者mOS比cN0/LND-患者更长(72个月vs.44个月,P=0.037)。对T分期进行分层分析,结果显示无论是T1/2期或T3/4期的pN0(HLN≥6枚)患者的mOS均长于相应的cN0/LND-患者。此外,pN0(HLN≥6枚)患者的mOS趋向于比pN0(HLN<6枚)患者更长(72个月vs.50个月,P=0.064)。结论:ICC术后pN0患者的OS优于cN0/LND-患者,且HLN≥6枚淋巴结的pN0患者比cN0/LND-患者预后更好。因此,从预后的角度看,在ICC中cN0并非pN0的理想替代指标。对于临床评估无淋巴结转移的ICC患者仍建议常规行淋巴结切除/清扫。 展开更多
关键词 肝内胆管癌 手术治疗 临床评估无淋巴结转移 病理评估无淋巴结转移 预后
下载PDF
胃癌病理类型及分期与胃癌组织中PI3K/CREB表达水平的相关性分析 被引量:2
5
作者 张小辉 王海伟 +2 位作者 孙颖 王静 王云鹏 《解剖学杂志》 CAS 2021年第6期491-496,共6页
目的:探究胃癌病理类型及分期与胃癌组织中磷脂酰肌醇3-激酶(PI3K)/cAMP反应序列结合蛋白(CREB)表达水平的相关性。方法:选取140例在本院手术的胃癌患者病例标本作为检测样本,同时选取胃癌患者距肿瘤边缘1 cm处的癌旁组织标本作对比。... 目的:探究胃癌病理类型及分期与胃癌组织中磷脂酰肌醇3-激酶(PI3K)/cAMP反应序列结合蛋白(CREB)表达水平的相关性。方法:选取140例在本院手术的胃癌患者病例标本作为检测样本,同时选取胃癌患者距肿瘤边缘1 cm处的癌旁组织标本作对比。用免疫组织化学、免疫印迹检测样本中PI3K、CREB阳性率及蛋白表达量。结果:PI3K、CREB在胃癌组织中的阳性率高于癌旁组织;PI3K/CREB在胃癌组织中的蛋白表达量均高于癌旁组织;胃癌组织中PI3K、CREB在低分化、Ⅲ+Ⅳ期中阳性表达率及蛋白水平均高于高中分化、Ⅰ+Ⅱ期中的表达;PI3K、CREB阳性胃癌患者生存率低于阴性患者;PI3K诊断胃癌的ROC曲线下面积(AUC)为0.765,灵敏度为78.64%、特异度为62.46%,CREB诊断胃癌AUC面积为0.774,灵敏度为70.93%、特异度为64.75%。结论:PI3K、CREB在胃癌组织中呈现高表达,且与胃癌疾病进展存在相关性,对胃癌预后诊断具有重要意义。 展开更多
关键词 胃癌 磷脂酰肌醇3-激酶 cAMP反应序列结合蛋白 病理淋巴结转移分期 免疫组织化学
下载PDF
术前颈部淋巴结临床体检和影像学阴性的口腔鳞状细胞癌术后病理确认淋巴结转移的相关影响因素分析 被引量:3
6
作者 李永红 於海军 +2 位作者 刘克 柯元 曾奕菲 《武汉大学学报(医学版)》 CAS 2018年第3期493-496,501,共5页
目的:探讨颈部淋巴结临床体检和影像学阴性(cN0)的口腔鳞状细胞癌患者术后病理确认颈部淋巴结转移的相关影响因素,为临床治疗提供参考依据。方法:回顾性分析117例cN0的口腔鳞癌患者的临床资料,均行原发灶扩大切除术联合颈部淋巴结清扫术... 目的:探讨颈部淋巴结临床体检和影像学阴性(cN0)的口腔鳞状细胞癌患者术后病理确认颈部淋巴结转移的相关影响因素,为临床治疗提供参考依据。方法:回顾性分析117例cN0的口腔鳞癌患者的临床资料,均行原发灶扩大切除术联合颈部淋巴结清扫术,术后病理确认颈部淋巴结转移区域和个数,通过单因素和多因素Logistic分析患者颈部淋巴结转移的影响因素。结果:117例患者中病理确认颈部淋巴结转移36例(30.77%),其中Ⅰ、Ⅱ、Ⅲ区转移率分别为27.78%、38.89%和22.22%;单因素分析结果显示,年龄、分化程度、生长方式及病灶直径是影响cN0口腔鳞癌颈部淋巴结术后病理确认转移的重要因素(P<0.05);多因素Logistic回归分析结果显示,分化程度、生长方式及病灶直径是颈部淋巴结转移发生的独立危险因素(P<0.05)。结论:分化程度、生长方式及病灶直径为cN0的口腔鳞癌患者颈部淋巴结术后病理确认转移的独立危险因素,对具备上述因素的cN0患者应给予对应颈部淋巴结清扫;未接受或不规范根治性颈清扫患者,如存在上述危险因素,相应区域术后放疗可能存在必要性。 展开更多
关键词 口腔鳞状细胞 颈部淋巴结临床阴性 颈部淋巴结清扫术 颈部淋巴结病理转移 危险因素
原文传递
Clinicopathological Characteristics as Predictive Factrs for Lymph Node Metastasis in Submucosal Gastric Cancer 被引量:1
7
作者 Caigang Liu Ping Lu Yang Lu Lua Li Ruishan Zhang Huimian Xu Shubao Wang Junqing Chen 《Chinese Journal of Clinical Oncology》 CSCD 2007年第4期237-240,共4页
OBJECTIVE To identify clinicopathological characteristics as predictive factors for lymph node metastasis in submucosal gastric cancer, and in addi- tion to establish objective criteria as indications for endoscopic s... OBJECTIVE To identify clinicopathological characteristics as predictive factors for lymph node metastasis in submucosal gastric cancer, and in addi- tion to establish objective criteria as indications for endoscopic submucosal dissection (ESD). METHODS Data from 130 patients with submucosal gastric cancer were collected, and the relationship between their clinicopathological characteris- tics and the presence of lymph node metastasis was retrospectively analyzed by multivariate analysis. RESULTS In the multivariate logistic regression model, a tumor size of 2 cm or more and an undifferentiated histologic type were found to be inde- pendent risk clinicopathological characteristics for lymph node metastasis. Among 130 patients with submucosal carcinoma, no lymph node metastases were observed in 17 patients who showed neither of the two risk clinicopath- ological characteristics. Lymph node metastasis occurred in 61.1% (22/36) of the patients who had both risk clinicopathological characteristics. CONCLUSION A tumor size of 2 cm or more and an undifferentiated histologic type were significantly and independently related to lymph node metastasis in submucosal gastric cancer. It is rational for the paitients with neither of these two independent risk clinicopathological characteristics to undergo an ESD. 展开更多
关键词 early gastric cancer lymph node METASTASIS clinicopathological characteristics endoscopic mucosal resection.
下载PDF
CLINICOPATHOLOGICAL CHARACTERISTICS OF ADVANCED COLORECTAL CANCER 30mm OR SMALLER IN DIAMETER
8
作者 Hong Zhang Chun-sheng Chen +3 位作者 Jin-chun Cong Lei Qiao Taisuke Hasegawa Shigeki Takashima 《Chinese Medical Sciences Journal》 CAS CSCD 2007年第2期98-103,共6页
Objective To investigate the clinicopathological characteristics of advanced colorectal cancer which was 30 mm or smaller in diameter. Methods Retrospective analysis documented 80 patients with small advanced colorect... Objective To investigate the clinicopathological characteristics of advanced colorectal cancer which was 30 mm or smaller in diameter. Methods Retrospective analysis documented 80 patients with small advanced colorectal cancer from May 1985 to May 2002. According to the diameter of tumors, all patients were divided into three groups: Group A (10 mm or less), Group B (11-20 mm), Group C (21-30 mm). Considering the number of patients in Group A was smaller, we combined Group A with Group B as Group D. Then various clinicopathological characteristics were compared between Group C and Group D. Results The most common site of small advanced colorectal cancer was sigmoid colon and rectum that accounted for 36.2% and 35.0% of all cases. The average diameter of total tumors was 23.3 mm. Type 2 was the most common macroscopic type (63.7%) and the moderate differentiation was seen in 77.5% of cases. Thirty-eight (47.5%) cases had lymph node metastasis. Three (3.8%) cases had liver metastasis and three (3.8%) cases had peritoneal metastasis. The frequency of lymph node metastasis was found significantly different between Group C and Group D (54.2% vs. 28.6%, P<0.05), as well as between the groups with different depth of invasion (P<0.05). Curability A resection was performed in 69 (86.2%) cases. Conclusions Tumor size and depth of invasion are related to lymph node metastasis in small advanced colorectal cancer. However, the small size of tumor may not always be a.reliable parameter for estimating the risk of lymph node metastasis. Small colorectal cancers also do not always mean the early stage. Surgeons should be aware of the features of small advanced colorectal cancers to select ideal management and perform perfect resection. 展开更多
关键词 advanced colorectal cancer small colorectal cancer lymph node metastasis clinicopathological characteristic
下载PDF
Nodal spread and micrometastasis within mesorectum
9
作者 CunWang Zong-GuangZhou +3 位作者 ZhaoWang Dai-YunChen Yang-ChunZheng Gao-PingZhao 《World Journal of Gastroenterology》 SCIE CAS CSCD 2005年第23期3586-3590,共5页
AIM: To study the distribution of positive lymph nodes within mesorectum and to investigate the possible micrometastasis in negative lymph nodes. METHODS: Large slice technique combined with tissue microarray was used... AIM: To study the distribution of positive lymph nodes within mesorectum and to investigate the possible micrometastasis in negative lymph nodes. METHODS: Large slice technique combined with tissue microarray was used in the pathologic study of 31 specimens.RESULTS: A total of 992 lymph nodes were harvested and cancer metastasis was found in 148 lymph nodes. Some positive lymph nodes were located in the outer layer of mesorectum and more at the same site of mesorectum as the primary tumor. Circumferential margin lymph node metastasis was observed in nine cases. No significant difference in occurrence of micrometastasis was observed in different stage tumors. CONCLUSION: Positive lymph nodes are distributed in mesorectum and micrometastasis can be found in negative lymph nodes. 展开更多
关键词 Rectal cancer MESORECTUM Lymph node
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部